Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus

Current Opinion in Pediatrics

Volumn 26, Issue 6, 2014, Pages 682-689

  Tasker, Robert C ^a   Vitali, Sally H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Hypothermia; Ketamine; Ketogenic diet; Midazolam; Pentobarbital; Refractory status epilepticus

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; DESFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MIDAZOLAM; PENTOBARBITAL; PROPOFOL; ANALGESIC AGENT; ANTICONVULSIVE AGENT; HYPNOTIC SEDATIVE AGENT;

CENTRAL NERVOUS SYSTEM; CONTINUOUS INFUSION; DISEASE CONTROL; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; GENERAL ANESTHESIA; HUMAN; IN VIVO STUDY; INDUCED HYPOTHERMIA; INTENSIVE CARE; KETOGENIC DIET; MINIMUM LUNG ALVEOLUS CONCENTRATION; PHYSICIAN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; CHILD; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES; STATUS EPILEPTICUS;

ANALGESICS; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ANTICONVULSANTS; CHILD; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTHERMIA, INDUCED; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; ISOFLURANE; KETAMINE; KETOGENIC DIET; MIDAZOLAM; PENTOBARBITAL; STATUS EPILEPTICUS;

EID: 84927694104     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000149     Document Type: Review

References (60)

1. Scott RC. Consequences of febrile seizures in childhood. Curr Opin Pediatr 2014; XX: YY-ZZ.
2. Abend NS, Loddenkemper T. Pediatric status epilepticus management. Curr Opin Pediatr 2014; XX: YY-ZZ.
3. Freilich ER, Schreiber JM, Zelleke T, Gaillard WD. Pediatric status epilepticus: identification and evaluation. Curr Opin Pediatr 2014; XX: YY-ZZ.
4. Wilkes R, Tasker RC. Pediatric intensive care treatment of uncontrolled status epilepticus. Crit Care Clin 2013; 29: 239-257.
5. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis. International League Against Epilepsy. Epilepsia 1993; 34: 592-596.
6. Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia 2011; 52 (Suppl 8): 53-56.
7. Tasker RC. Midazolam for refractory status epilepticus: higher dosing and more rapid and effective control. Intensive Care Med 2006; 32: 1935-1936.
8. Federman MD, Kelly R, Harrison RE. Refractory metabolic acidosis as a complication of high-dose midazolam infusion for pediatric status epilepticus. Clin Neuropharm 2009; 32: 340-341.
9. Wilkes R, Tasker RC. Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies. Pediatr Crit Care Med 2014; 15: 632-639.
10. Igartua J, Silver P, Maytal J, et al. Midazolam coma for refractory status epilepticus in children. Crit Care Med 1999; 27: 1982-1985.
11. Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med 2006; 32: 2070-2076.
12. Tasker RC. Electroencephalographic seizure activity in the comatose critically ill child: getting closer to knowing what to do. Crit Care Med 2013; 41: 362-363.
13. Sanchez SM, Carpenter J, Chapman KE, et al. Pediatric ICU EEG monitoring: current resources and practice in the United States and Canada. J Clin Neurophysiol 2013; 30: 156-160.
14. Payne ET, Hahn CD. Continuous electroencephalography for seizures and status epilepticus. Curr Opin Pediatr 2014; XX: YY-ZZ.
15. US Food and Drug Administration. Label approved on 04/14/2008 for DIPRIVAN, NDA no. 019627. www.accessdata.fda.gov/drugsatfda-docs/label/2008/019627s046lbl.pdf. [Accessed 25 August 2014].
16. Owens J. Medical management of refractory status epilepticus. Semin Pediatr Neurol 2010; 17: 176-181.
17. Stullken EH, Milde JH, Michenfelder JD, et al. The nonlinear responses of cerebral metabolism to low concentrations of halothane, enflurane, isoflurane, and thiopental. Anesthesiology 1977; 46: 28-34.
18. Barberio M, Reiter PD, Kaufman J, et al. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol 2012; 27: 721-726.
19. Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic for refractory status epilepticus. Epilepsia 1999; 40: 759-762.
20. Schreiber JM, Gaillard WD. Treatment of refractory status epilepticus in childhood. Curr Neurol Neurosci Rep 2011; 11: 195-204.
21. Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia 2007; 48 (Suppl 8): 52-55.
22. Sakuma H, Awaya Y, Shiomi M, et al. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand 2010; 121: 251-256.
23. Kim SJ, Lee DY, Kim JS. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol 2001; 25: 217-220.
24. Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002; 43: 146-153.
25. Fernandez A, Lantigua H, Lesch C, et al. High-dose midazolam infusion for refractory status epilepticus. Neurology 2014; 82: 359-365.
26. Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014; 82: 656-664.
27. Pugin D, Foreman B, De Marchis GM, et al. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care 2014; 18: R103.
28. Schmutzhard E, Pfausler B. Complications of the management of status epilepticus in the intensive care unit. Epilepsia 2011; 52 (Suppl 8): 39-41.
29. Holmes GL, Riviello JJ Jr. Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999; 20: 259-264.
30. Rosati A, L'Erario M, Ilvento L, et al. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurol 2012; 79: 2355-2358.
31. Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013; 54: 1498-1503.
32. Kofke WA, Snider MT, Young RS, et al. Prolonged low flow isoflurane anesthesia for status epilepticus. Anesthesiology 1989; 71: 653-659.
33. Fugate JE, Burns JD, Wijdicks EFM, et al. Prolonged high-dose isoflurane for refractory status epilepticus: is it safe? Anesth Analg 2010; 111: 1520-1524.
34. Arnold JH, Truog RD, Rice SA. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg 1993; 76: 520-526.
35. Kelsall AW, Ross-Russell R, Herrick MJ. Reversible neurologic dysfunction following isoflurane sedation in pediatric intensive care. Crit Care Med 1994; 22: 1032-1034.
36. McBeth C, Watkins TG. Isoflurane for sedation in a case of congenital myasthenia gravis. Br J Anaesth 1996; 77: 672-674.
37. Hughes J, Leach HJ, Choonara I. Hallucinations on withdrawal of isoflurane used as sedation. Acta Paediatr 1993; 82: 885-886.
38. Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med 2006; 32: 927-933.
39. Mirski M, Williams M, Hanley DF. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995; 23: 400-404.
40. Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012; 40: 2677-2684.
41. Fountain NB, Fugate JE. Refractory status epilepticus. What to put down: the anesthetics or the patient? Neurology 2014; 82: 650-651.
42. Rossetti AO, Bleck TP. What's new in status epilepticus? Intensive Care Med 2014; 40: 1359-1362.
43. Orlowski JP, Erenberg G, Lueders H, Cruse RP. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 1984; 12: 367-372.
44. Nakagawa T, Fujita K, Saji Y, et al. Induced hypothermia/normothermia with general anesthesia prevents neurological damage in children with febrile refractory status epilepticus. No To Hattatsu 2011; 43: 459-463.
45. Imataka G, Wake K, Yamanouchi H, et al. Brain hypothermia therapy for status epilepticus in childhood. Eur RevMed Pharmacol Sci 2014; 18: 1883-1888.
46. Guilliams K, Rosen M, Buttram S, et al. Hypothermia for pediatric refractory status epilepticus. Epilepsia 2013; 54: 1586-1594.
47. Villeneuve N, Pinton F, Bahi-Buisson N, et al. The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol 2009; 51: 276-281.
48. Kumada T, Miyajima T, Kimura N, et al. Modified Atkins diet for the treatment of nonconvulsive status epilepticus in children. J Child Neurol 2010; 25: 485-489.
49. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010; 51: 2033-2037.
50. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011; 52: 1956-1965.
51. Nam SH, Lee BL, Lee CG, et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia 2011; 52: e181-e184.
52. Vaccarezza M, Silva W, Maxit C, Agosta G. Super-refractory status epilepticus: treatment with ketogenic diet in pediatrics. Rev Neurol 2012; 55: 20-25.
53. Jung da E, Kang HC, Lee JS, et al. Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy. Brain Dev 2012; 34: 620-624.
54. Caraballo RH, Reyes G, Avaria MF, et al. Febrile infection-related epilepsy syndrome: a study of 12 patients. Seizure 2013; 22: 553-559.
55. O'Connor SE, Richardson C, Trescher WH, et al. The ketogenic diet for the treatment of pediatric status epilepticus. Pediatr Neurol 2014; 50: 101-103.
56. Cobo NH, Sankar R, Murata KK, et al. The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units. J Child Neurol 2014. [Epub ahead of print]
57. Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in superrefractory status epilepticus. Neurology 2014; 82: 665-670.
58. Sort R, Born AP, Pedersen KN, et al. Ketogenic diet in 3 cases of childhood refractory status epilepticus. Eur J Neurol 2013; 17: 531-536.
59. Strzelczyk A, Reif PS, Bauer S, et al. Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure 2013; 22: 581-583.
60. Sánchez Fernández I, Abend NS, Agadi S, et al. Gaps and opportunities in refractory status epilepticus research in children: a multicenter approach by the Pediatric Status Epilepticus Research Group (pSERG). Seizure 2014; 23: 87-97.